Velico Medical
Velico Medical is a Beverly, Massachusetts-based medical technology company that develops spray dried plasma manufacturing systems — the veliPod and FrontlineODP — enabling decentralized, cold-chain-free plasma production for military, defense, and emergency healthcare customers.
- Company typePrivate
- Founded1991
- HeadquartersBeverly, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Velico Medical does
Velico Medical is a privately held medical technology company founded in 1991 and headquartered in Beverly, Massachusetts, specializing in spray dried plasma manufacturing systems. The company's core technology enables decentralized production of plasma products without cold chain infrastructure, addressing global plasma shortages and the limitations of traditional plasma storage and distribution. Velico's product portfolio comprises two systems: the veliPod™, a containerized manufacturing unit capable of producing up to 9,000 units of spray dried plasma annually and designed for deployment in frontline and remote settings, and the FrontlineODP™, an industrial-scale manufacturing system targeted at broader commercial and defense applications with planned capacity approaching one million units annually across planned facilities in North America, Europe, and the Indo-Pacific.
The company's primary customer segment is military and defense organizations, with the French Armed Forces Blood Transfusion Centre (CTSA) representing its first disclosed commercial customer following the world-first deployment of the veliPod in Paris in February 2026. Secondary targets include healthcare systems and emergency medical services requiring reliable plasma supply for disaster response and remote medical facilities. Velico's business model combines direct government/military sales with grant-based funding, having received $19 million from BARDA in 2017, an investment from New York Angels in 2024, and €1 million from the French Military in 2026. The company operates with 11-50 employees and is in an early commercialization phase, with revenue not publicly disclosed.
Velico's competitive positioning rests on its proprietary spray dried plasma technology and the logistical advantages of cold-chain-free, decentralized production. The technology has been validated through BARDA funding and military deployment, suggesting the company has navigated complex biodefense and pharmaceutical regulatory pathways. Distribution channels and pricing details are not publicly disclosed, but the company's go-to-market appears centered on direct engagement with government and military procurement channels, with planned expansion into broader healthcare and emergency response markets as manufacturing capacity scales.
Velico Medical firmographics
Firmographics- Name
- Velico Medical
- Website
- https://velicomedical.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Velico Medical is a Beverly, Massachusetts-based medical technology company that develops spray dried plasma manufacturing systems — the veliPod and FrontlineODP — enabling decentralized, cold-chain-free plasma production for military, defense, and emergency healthcare customers.
- Ownership category
- akta.pro rank
Velico Medical industry classification
Industry- Product category
- Medical Devices — Blood and Plasma Manufacturing Systems
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- akta.pro primary industry
- Plasma Fractionation & Purification Manufacturing (HLAIAHAI)
- akta.pro secondary industry
- Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)
Keywords
Where Velico Medical is headquartered
LocationHeadquarters
- HQ city
- Beverly
- HQ country
- United States
- HQ region
- North America
Markets served
Velico Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Infrastructure
Velico Medical product offering
Product offeringCore offering
Velico Medical designs, develops, and manufactures proprietary spray dried plasma manufacturing systems — the veliPod™ containerized system for military/frontline deployment and the FrontlineODP™ industrial-scale system for broader commercial and defense use. The systems enable decentralized production of spray dried plasma without cold chain requirements or heavy infrastructure, supporting trauma care, emergency transfusion, and national medical preparedness.
Product overview
Velico Medical offers a portfolio of spray dried plasma manufacturing systems comprising the veliPod™ for military deployment and the FrontlineODP™ for broader commercial and defense applications. Both products eliminate cold chain storage requirements and heavy infrastructure dependencies, enabling decentralized plasma production. The veliPod™ is a compact, containerized system deployed by militaries, while the FrontlineODP™ represents the company's scaled manufacturing platform designed for near-million unit annual capacity across multiple geographic regions.
Differentiator
Problem solved
Functional benefit
Brands
- veliPod: Containerized spray dried plasma manufacturing system designed for decentralized plasma production, enabling production of up to 9,000 units of spray dried plasma annually without cold chain requirements or heavy infrastructure.
- FrontlineODP
Products and services
- veliPod™ Containerized spray dried plasma manufacturing system designed for military deployment. The veliPod enables production of up to 9,000 units of spray dried plasma annually without cold chain requirements or heavy infrastructure, supporting battlefield trauma care, military medical preparedness, and remote plasma supply. It is intended for armed forces blood transfusion centers and defense medical programs.
- FrontlineODP™ Spray Dried Plasma Manufacturing System Industrial-scale spray dried plasma manufacturing system for commercial and defense use. The FrontlineODP supports production of nearly one million plasma units annually, with planned manufacturing facilities in North America, Europe, and the Indo-Pacific, and is intended for healthcare systems, emergency medical services, and defense customers requiring large-scale decentralized plasma supply.
Quantifiable outcome
- Produces up to 9,000 units of spray dried plasma annually per veliPod system
- +2 more outcomes
Companies that use Velico Medical
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Velico Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Velico Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- French Armed Forces Blood Transfusion Centre (CTSA)coreFrance's Armed Forces Blood Transfusion Centre (CTSA) in Paris received Velico Medical's first veliPod containerized spray dried plasma manufacturing system on February 17, 2026. This represents a world-first deployment of decentralized plasma production technology for military use, marking a strategic partnership in advancing military trauma care capabilities.
Scale indicators4 records
Recent moves9 records
Expansion highlights5 records
Velico Medical competitors and assessment
Company assessmentBroad incumbents
- Kedrion Biopharma: Plasma-derived therapy manufacturer with significant military and rare disease franchises, including collaborations on dried plasma products. Comparable as a downstream plasma therapeutics company operating in overlapping end markets and with prior interest in decentralized/dried plasma formats.
- CSL Behring: Global plasma fractionator and manufacturer of plasma-derived therapies, with deep relationships with blood collection centers. Comparable as a large incumbent that depends on upstream plasma supply technologies of the kind Velico is developing.
- Grifols: One of the world's largest plasma fractionators, producing plasma-derived therapeutics (immunoglobulins, albumin, clotting factors). Comparable as a major player in the plasma-derived therapy value chain that Velico's spray dried plasma supply could feed into.
- Fresenius Kabi (Transfusion Medicine): Major diversified healthcare company supplying blood collection bags, processing solutions, and transfusion medicine equipment globally, including products for plasma production. Comparable as a broad incumbent in the same end-to-end plasma supply chain.
- Octapharma: Privately held global plasma fractionator producing immunoglobulins, coagulation factors, and other plasma-derived therapies. Comparable as a major downstream consumer of plasma supply technologies and as a potential strategic partner or acquirer of plasma supply innovations.
Direct peers
- Cerus Corporation: Developer of the INTERCEPT pathogen reduction system for platelets, plasma, and whole blood, sold to blood centers and military/defense customers. Comparable as a blood-product safety and processing technology company targeting the same transfusion medicine and military trauma end markets.
- MacoPharma: Specialized manufacturer of blood bag systems, plasma processing devices, and pathogen reduction/inactivation solutions for transfusion medicine. Comparable as a focused supplier of plasma manufacturing and processing technologies to blood centers and defense customers.
- Terumo BCT: Global leader in blood component collection, processing, and storage equipment, including apheresis systems and pathogen reduction technologies. Directly comparable as a supplier of capital equipment and disposables used to manufacture and deliver blood/plasma products to hospitals, blood banks, and military medical services.
- Haemonetics Corporation: Manufacturer of blood and plasma component collection and processing equipment, including plasma collection systems sold to source plasma collectors. Comparable as a medical device company whose capital equipment underpins the blood/plasma supply chain.
Regional players
- B Medical Systems: Manufacturer of medical cold chain equipment including blood bank refrigerators and plasma freezers used by militaries and humanitarian organizations. Comparable as a supplier of blood/plasma logistics infrastructure to military and emergency response customers, even though Velico's value proposition is to displace cold chain rather than support it.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Velico Medical social profiles
Digital presenceVelico Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Velico Medical leadership team
Management profileNumber of profiles
Profiles6 records
Velico Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Velico Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Velico Medical
What does Velico Medical do?
Velico Medical designs, develops, and manufactures proprietary spray dried plasma manufacturing systems — the veliPod™ containerized system for military/frontline deployment and the FrontlineODP™ industrial-scale system for broader commercial and defense use. The systems enable decentralized production of spray dried plasma without cold chain requirements or heavy infrastructure, supporting trauma care, emergency transfusion, and national medical preparedness.
When was Velico Medical founded?
Velico Medical was founded in 1991. It employs 51 to 100 people.
Where is Velico Medical based?
Velico Medical is headquartered in Beverly, United States, in the North America region.
Who are Velico Medical's main competitors?
Broad incumbents on record are Kedrion Biopharma, CSL Behring, Grifols, Fresenius Kabi (Transfusion Medicine) and Octapharma. Direct peers are Cerus Corporation, MacoPharma, Terumo BCT and Haemonetics Corporation. B Medical Systems is listed as a regional player.
Does Velico Medical have an API?
No public API is recorded for Velico Medical.
What industry is Velico Medical in?
Velico Medical's product category is Medical Devices — Blood and Plasma Manufacturing Systems. Its primary akta.pro industry code is HLAIAHAI, Plasma Fractionation & Purification Manufacturing, with a secondary code of HLAAAAAI, Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors). Its NAICS code is 3391.